Vaccine Supply

Current Vaccine Shortages (Exit Site)
This web page provides the latest national information about vaccine supply, shortages, and delays.

Communications from Manufacturers about Supply

  • Haemophilus influenzae type b (PedivaxHIB®) Vaccine Shortage
    The AAP and CDC are advising pediatricians to continue to defer the booster dose of Haemophilus influenzae type B (Hib) vaccine for healthy children at the 12- through 15-month well-child visit until at least mid-2009. These interim recommendations remain in effect until the Hib vaccine supply is adequate to provide all children with all doses of the vaccine. The Academy and CDC are monitoring Hib vaccine supply and will make additional recommendations if the need arises.

    In December 2007, Merck temporarily suspended manufacturing of its Hib-containing vaccines during a change in manufacturing processes and voluntarily recalled certain lots of PedvaxHIB (monovalent Hib vaccine) and Comvax (Hib-HepB) ( MMWR 2007;56(Dispatch):1-2 [Medline] ).

    Health care clinicians should register and track children in whom the booster dose is deferred to facilitate recalling them for vaccination when supply improves, according to the interim recommendations.

    The supply of ActHIB and Pentacel is adequate to cover the three-dose primary series through mid-2009, according to sanofi pasteur, the other manufacturer of Hib-containing vaccines. CDC is continuing to work with sanofi pasteur to review its Hib vaccine supply and capacity to serve the U.S. market during the next six to eight months.

    Updates on vaccine availability will be provided as more information becomes available. Information on current vaccine supply issues may be found on the CDC Web site. (2/20/09)

  • Hepatitis A Vaccine Supply
    As of December 1, 2008, Merck's Pediatric/Adolescent formulation of hepatitis A vaccine, VAQTA®, is available for ordering. Merck estimates that the Adult formulation of VAQTA® will be available in second quarter 2009. GSK production and supply of their Pediatric and Adult hepatitis A vaccine (Pediatric & Adult Havrix®) and their Adult hepatitis A/hepatitis B combination vaccine (Twinrix®) are in adequate supply to meet demand. (2/20/09)

  • ProQuad (Merck): There is adequate supply of Varivax® (varicella vaccine) to fully implement the recommended 2-dose immunization schedule for all age groups, including catch-up.  ProQuad® (MMRV) will not be available in 2009.

Status of Licensure and Recommendations for New Vaccines - New from AAP Red Book Online(Exit Site)
This table provides up-to-date information on the status of recommendations for new vaccines and is freely accessible to all visitors by clicking the link above.

Understanding Vaccine Research & Development, Licensure, and the Recommendation Process (Exit Site)
Dr Margaret Rennels, Dr John Bradley, and Dr Larry Pickering, describe the comprehensive process of adding new vaccine recommendations to the immunization schedule. Reprint permission for this article courtesy of AAP News.

Manufacturers and Distributors Phone Numbers
Link to vaccine manufacturers and distributors telephone numbers.

Resources:

 

 

 



 

SEARCH CISP

 
 
AAP Member Center

 
2009 Childhood Immunization Schedule/Adolescent/Catch-up Schedule

 
June Issue: AAP Immunization Initiatives Newsletter (PDF 386KB)

 

 

CONTACT US:
cispimmunize@aap.org






*Links, organizations, information and resources contained within this site do not constitute an endorsement by the American Academy of Pediatrics. The AAP is not responsible for the content of these resources.